Table III.
Independent predictors of 1-year all-cause mortality and major adverse clinical events
| Parameter | HR (95% CI) | P-value |
|---|---|---|
| All-cause mortality: | ||
| Age | 1.07 (1.04, 1.09) | < 0.001 |
| Gender | 1.64 (1.009, 2.65) | 0.046 |
| Hypertension | 6.73 (0.91, 49.6) | 0.06 |
| Diabetes | 1.55 (0.96, 2.50) | 0.07 |
| Prior MI | 0.98 (0.59, 1.65) | 0.95 |
| Baseline creatinine | 1.12 (1.02, 1.23) | 0.02 |
| LVEF < 50% | 2.39 (1.44, 3.95) | 0.001 |
| Highest troponin I | 1.003 (1.02, 1.23) | 0.04 |
| Normal geometry (reference) | 1 | |
| Concentric hypertrophy | 0.80 (0.47, 1.38) | 0.43 |
| Eccentric hypertrophy | 1.08 (0.55, 2.09) | 0.83 |
| MACE: | ||
| Age | 1.04 (1.02, 1.05) | < 0.001 |
| Gender | 1.56 (1.12, 2.16) | 0.008 |
| Hypertension | 1.02 (0.57, 1.81) | 0.95 |
| Diabetes | 1.49 (1.07, 2.06) | 0.02 |
| Prior MI | 1.11 (0.78, 1.58) | 0.58 |
| Baseline creatinine | 1.10 (1.04, 1.18) | 0.002 |
| LVEF < 50% | 1.57 (1.12, 2.20) | 0.008 |
| Highest troponin I | 1.004 (1.001, 1.006) | 0.004 |
| Normal geometry (reference) | 1 | |
| Concentric LVH | 0.97 (0.67, 1.41) | 0.89 |
| Eccentric hypertrophy | 1.576 (1.006, 2.470) | 0.047 |
LVEF – left ventricular ejection fraction, LVH – left ventricular hypertrophy, MACE – major adverse cardiac events; defined as cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and hospitalization for bleeding, MI – myocardial infarction.